FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics. Described is an anticonvulsant and tranquilising agent with the general formula of:
where R=CH2CH2NH2 HBr (derivative 1); R=CH2CH2CH2NH2 HBr (derivative 2); R=CH2(CH2)4NH2 HBr (derivative 3); R=p-CH2NEt2 HCl (derivative 4); R=m-CH2NEt2 HCl (derivative 5).
EFFECT: invention provides considerable reduction of time of pharmacological effect coming, as well as reduction of negative side effects.
1 cl, 7 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR TREATING SPASMODIC SYNDROME CASES | 2006 |
|
RU2314829C1 |
PHARMACEUTICAL COMPOSITION FOR THE ELIMINATION OF CONVULSIVE SYNDROME BASED ON NIKETHAMIDE AND MEDICINAL PRODUCTS OF THE BENZODIAZEPINE GROUP | 2022 |
|
RU2801050C1 |
2-BENZOYLAMINOMETHYLBENZIMIDAZOLE HYDROCHLORIDE SHOWING ANTISPASMODIC, ANTIHYPOXIC AND ANTITOXIC EFFECTS AT DIFFERENT CONVULSIVE AGENTS EFFECT | 1994 |
|
RU2109737C1 |
2-AMINO-5,5-DIMETHYL-4,5-DIHYDRO-7H-PYRANO-[4,3-D]-THIAZOLE SHOWING TRANQUILIZING ACTIVITY | 1987 |
|
SU1441749A1 |
PHARMACEUTICAL COMPOSITION WITH ANTICONVULSANT ACTIVITY FOR PARENTERAL INTRODUCTION | 2011 |
|
RU2463052C1 |
ANTICONVULSANT | 2018 |
|
RU2705810C1 |
(1-METHYLPIPERIDIN-4-YL)-2-PROPYL PENTANOATE HYDROCHLORIDE, HAVING CHOLINOLYTIC AND ANTICONVULSANT ACTIVITY | 2019 |
|
RU2714135C1 |
N-(γ-ANINOBUTYRYL)-1-AZA-4,7,10,13- TETRAOXACYCLOPENTADECANE-HYDROCHLORIDE HAVING ANTIHYPOXIA AND ANTICONVULSIVE ACTIVITY | 1984 |
|
SU1197407A1 |
COUMARIN, THIOCOUMARIN AND QUINOLINONE DERIVATIVES, HAVING ANTICONVULSANT ACTIVITY | 2017 |
|
RU2720510C2 |
METHOD OF TREATMENT OF NEUROSIS-LIKE AND MARGINAL DISORDERS | 1993 |
|
RU2102986C1 |
Authors
Dates
2016-08-10—Published
2015-04-20—Filed